"CRS conducts Phase II-IV clinical trials for both pharmaceutical companies and contract research organizations."

During the past decade, Clinical Research Solutions conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 11 clinical trials were completed, i.e. on average, 30.6% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 9 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Solutions" #1 sponsor was "Urovant Sciences GmbH" with 5 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "UroGen Pharma Ltd." with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Solutions" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Foundation Medicine" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Solutions" are "Overactive Bladder" (5 trials), "Bladder Cancer" (4 trials), "Prostate Cancer" (3 trials), "Urothelial Carcinoma Bladder" (3 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Clinical Research Solutions" in a lesser frequency.

Most popular intervention types in "Clinical Research Solutions" are "Drug" (32 trials), "Other" (3 trials), "Biological" (2 trials), "Diagnostic Test" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Vibegron" (4 trials), "Enzalutamide" (3 trials), "BMS-986165" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Solutions" are 25 trials for "All" genders, 13 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Solutions". undefined are not yet recruiting, 8 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Clinical Research Solutions, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Solutions, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".